Intro

This chapter examines how cutting-edge technologies like xenotransplantation and digitizing smell can revolutionize medicine and society. It also discusses the role of financial strategies for startups and the importance of predicting risks in the rapidly evolving tech landscape.

Transcript

chevron_right

Play full episode

chevron_right

Transcript

Episode notes

Josh Wolfe is a co-founder of Lux Capital, where he funds the kinds of ventures that change everything: think gene-edited pig organs and technology that lets you “record” smells. His approach? Relentless curiosity. He reads dozens of newspapers daily to identify patterns, always staying a few steps ahead. In this episode of The Generalist, Josh shares how his firm backs companies that don’t just predict the future, but create it.

In our conversation, we explore:

• The revolutionary development of genetically modified pig organs being transplanted into humans and what this means for the future of organ transplantation.

• The recent achievement of "teleporting smell" across space and why computers that can replicate scents will open up entirely new industries.

• Why Lux is investing in the search for real-life "X-Men" — genetic outliers in isolated populations whose DNA could lead to life-saving medical advancements.

• How Josh evaluates macro trends to make smarter micro investment decisions and why ignoring the big picture is a mistake.

• The three tech sectors that Josh believes will define the geopolitical balance in the decades ahead.

• How Josh stays current on macroeconomic trends.

• Much more

—

Thank you to the partners who make this possible

Brex: The banking solution for startups.

WorkOS: The modern identity platform for B2B SaaS.

Generalist+: Essential intelligence for modern investors and technologists.
—

For a full transcript of the episode, please visit: https://thegeneralist.substack.com/p/shrinking-the-gap-between-sci-fi-and-sci-fact-josh-wolfe

—

Timestamps